ScripPureTech Health plc, after the multibillion-dollar success of its last neuropsychiatry venture Karuna Therapeutics Inc., launched Seaport Therapeutics in April with $100m in series A funding and on 21
ScripAfter a six-month search to find a permanent replacement for research chief John Reed, Sanofi has dipped into the venture capital sector and appointed Houman Ashrafian as its new head of R&D, effect
In VivoAs 2022 drew to a close, US President Joe Biden quietly signed a law that rewarded countless researchers and animal-rights activists with a long-sought goal – ending a decades-old requirement that all
In VivoA publication in the May 25th issue of Science Translational Medicine ( STM ) suggests that gut microbiota may activate a type of unconventional T cell called MAIT (mucosal-associated invariant T ce